RT
Renaissance Technologies LLC cut its BOLT stake below 5%
Renaissance Technologies LLC reported owning 4.8% of Bolt Biotherapeutics, Inc. (BOLT) (92,925 shares) in a Schedule 13G filed Nov 12, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 12, 2026
- Source
- Schedule 13G